156 related articles for article (PubMed ID: 9622202)
1. Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.
Endo A; Nagai N; Urano T; Ihara H; Takada Y; Hashimoto K; Takada A
Neurosci Lett; 1998 Apr; 246(1):37-40. PubMed ID: 9622202
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus.
Endo A; Nagai N; Urano T; Takada Y; Hashimoto K; Takada A
Neurosci Res; 1999 Jan; 33(1):1-8. PubMed ID: 10096465
[TBL] [Abstract][Full Text] [Related]
3. The activation of the tissue plasminogen activator-plasmin system induced in the mouse hippocampus after injection of trimethyltin: possible proteolysis of highly polysialylated NCAM.
Endo A; Hashimoto K; Takada Y; Takada A
Jpn J Physiol; 1999 Oct; 49(5):463-6. PubMed ID: 10603431
[TBL] [Abstract][Full Text] [Related]
4. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
5. The Role of Fibrinolytic System in Health and Disease.
Kwaan HC
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
[TBL] [Abstract][Full Text] [Related]
6. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice.
Nagai T; Kamei H; Ito M; Hashimoto K; Takuma K; Nabeshima T; Yamada K
J Neurochem; 2005 Jun; 93(5):1272-9. PubMed ID: 15948318
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen and plasmin activity in patients with coronary artery disease.
Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
[TBL] [Abstract][Full Text] [Related]
8. Myosin as cofactor and substrate in fibrinolysis.
Machovich R; Ajtai K; Kolev K; Owen WG
FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
10. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
11. Urokinase regulates embryonic cardiac cushion cell migration without converting plasminogen.
Gorny KN; Brauer PR
Anat Rec; 1999 Nov; 256(3):269-78. PubMed ID: 10521785
[TBL] [Abstract][Full Text] [Related]
12. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
14. Plasmin-independent gelatinase B (matrix metalloproteinase-9) release by monocytes under the influence of urokinase.
Menshikov MY; Elizarova EP; Kudryashova E; Timofeyeva AV; Khaspekov Y; Beabealashvilly RS; Bobik A
Biochemistry (Mosc); 2001 Sep; 66(9):954-9. PubMed ID: 11703174
[TBL] [Abstract][Full Text] [Related]
15. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
[TBL] [Abstract][Full Text] [Related]
16. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus.
Salles FJ; Strickland S
J Neurosci; 2002 Mar; 22(6):2125-34. PubMed ID: 11896152
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix degradation by cultured mesangial cells: mediators and modulators.
Baricos WH; Reed JC; Cortez SL
Exp Biol Med (Maywood); 2003 Oct; 228(9):1018-22. PubMed ID: 14530509
[TBL] [Abstract][Full Text] [Related]
18. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
[TBL] [Abstract][Full Text] [Related]
19. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
20. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator.
Goldfinger LE; Stack MS; Jones JC
J Cell Biol; 1998 Apr; 141(1):255-65. PubMed ID: 9531563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
